Pharming Group N.V. (PHAR) Misses Q1 EPS by 1c

Pharming Group N.V. (NASDAQ: PHAR) reported Q1 EPS of ($0.02), $0.01 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $79.09 million versus the consensus estimate of $64 million.

For earnings history and earnings-related data on Pharming Group N.V. (PHAR) click here.

You May Also Be Interested In

• China semiconductor equipment imports grow 9% in July, Barclays comments
• 'We expect salesforce.com (CRM) to capture a meaningful share of next-gen agentic workflows': Cantor
• Benchmark Reiterates Hold Rating on Codexis, Inc. (CDXS) Amid Transition to New Products/Services